Cancer screening rates are significantly lower in FQHCs

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

A national study led by researchers at MD Anderson Cancer Center and the University of New Mexico Comprehensive Cancer Center found major gaps in breast, cervical, and colorectal cancer screening use in Federally Qualified Health Centers in the US, relative to overall screening rates in the country.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Biologic drugs play an important role in treating cancers such as breast cancer and lymphoma, but their high costs can add to the financial burden of cancer care. Now, lower-cost versions known as biosimilars are gaining ground, and a study led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center suggests their growing use is associated with lower costs for both insurers and patients.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login